Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) Total Receivables: ₺166 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:EGEPO Nasmed Ozel Saglik Hizmetleri Ticaret AS IST:EGEPO
73 GF Score
Price ₺18.28
GF Value ₺8.41
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Nasmed Ozelglik Hizmetleri Ticaret AS Total Receivables?

Nasmed Ozelglik Hizmetleri Ticaret AS IST:EGEPO -2.45% 73 Total Receivables is ₺166 Mil as of Dec. 2025. GuruFocus rates IST:EGEPO with a GF Score™ of 73/100 and a GF Value™ of ₺8.41 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Nasmed Ozelglik Hizmetleri Ticaret AS's Total Receivables for the quarter that ended in Dec. 2025 was ₺166 Mil.

Nasmed Ozelglik Hizmetleri Ticaret AS Total Receivables Related Terms

Nasmed Ozelglik Hizmetleri Ticaret AS Total Receivables Historical Data

* Premium members only.

The historical data trend for Nasmed Ozelglik Hizmetleri Ticaret AS's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nasmed Ozelglik Hizmetleri Ticaret AS Total Receivables Chart

Nasmed Ozelglik Hizmetleri Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Receivables
Get a 7-Day Free Trial 18.96 19.92 49.87 136.89 135.65

Nasmed Ozelglik Hizmetleri Ticaret AS Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 135.65 111.73 115.47 149.90 165.64
IST:EGEPO
73GF Score
Nasmed Ozel Saglik Hizmetleri Ticaret AS IST:EGEPO
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nasmed Ozelglik Hizmetleri Ticaret AS Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₺166 Mil mean?
Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) has a Total Receivables of ₺166 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Nasmed Ozelglik Hizmetleri Ticaret AS and its competitors.
Is Nasmed Ozelglik Hizmetleri Ticaret AS's Total Receivables too high?
Nasmed Ozelglik Hizmetleri Ticaret AS's current Total Receivables is ₺166 Mil. Overall, Nasmed Ozelglik Hizmetleri Ticaret AS has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nasmed Ozelglik Hizmetleri Ticaret AS's Total Receivables compare to HCA and THC?
Nasmed Ozelglik Hizmetleri Ticaret AS's Total Receivables of ₺166 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Healthcare Providers & Services company?
A good Total Receivables depends on the Healthcare Providers & Services industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Nasmed Ozelglik Hizmetleri Ticaret AS and its competitors. Nasmed Ozelglik Hizmetleri Ticaret AS's current Total Receivables is ₺166 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nasmed Ozelglik Hizmetleri Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺8.41, compared to a current price of ₺18.28 — trading 117.4% above its estimated fair value. The current Total Receivables is ₺166 Mil. Nasmed Ozelglik Hizmetleri Ticaret AS's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO), the current Total Receivables is ₺166 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) Overvalued in 2026?

Based on GuruFocus' analysis, Nasmed Ozelglik Hizmetleri Ticaret AS stock appears to be overvalued. The current stock price of ₺18.28 is trading 117.4% above its estimated GF Value™ of ₺8.41. GuruFocus considers Nasmed Ozelglik Hizmetleri Ticaret AS to be Significantly Overvalued.

Key valuation signals for IST:EGEPO:

  • Total Receivables: ₺166 Mil
  • GF Value™: ₺8.41 vs. price of ₺18.28 (117.4% above fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the IST:EGEPO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nasmed Ozelglik Hizmetleri Ticaret AS Business Description

Address Iller Bankasi Halide Edip Adivar Bulvar, 507. Sk. No:3, Izmir, TUR, 35270
Nasmed Ozel Saglik Hizmetleri Ticaret AS provides quality healthcare services. It arranges consultations, travel planning, accommodation, translation, and other relevant services for its patients 24/7.
73GF Score

Get the complete analysis for IST:EGEPO

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺18.28
Price
₺8.41
GF Value